Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

15 trials with published results (17%)

Research Maturity

54 completed trials (63% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

4.7%

4 terminated out of 86 trials

Success Rate

93.1%

+6.6% vs benchmark

Late-Stage Pipeline

30%

26 trials in Phase 3/4

Results Transparency

28%

15 of 54 completed with results

Key Signals

15 with results93% success

Data Visualizations

Phase Distribution

61Total
Not Applicable (17)
P 1 (7)
P 2 (11)
P 3 (7)
P 4 (19)

Trial Status

Completed54
Unknown13
Recruiting6
Withdrawn5
Terminated4
Not Yet Recruiting2

Trial Success Rate

93.1%

Benchmark: 86.6%

Based on 54 completed trials

Clinical Trials (86)

Showing 20 of 20 trials
NCT07678073Not ApplicableRecruiting

Comparison of the Effects of General Anesthesia and Combined Spinal-Epidural Anesthesia on Ferroptosis, Humanin and MOTS-c Levels in Renal Transplantation

NCT07100925Phase 1Withdrawn

A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma

NCT07645599Not Yet Recruiting

Microvasculature Ultrasound Super-resolution in Transplant Delayed Graft Function

NCT02894606CompletedPrimary

Influence of Thymoglobuline on Phenotypic and Functional Profiles of B Lymphocytes in Renal Transplant Recipients

NCT03016455CompletedPrimary

B Cell Lymphocyte in Humoral Rejection and Alloimmunisation

NCT04838288Phase 4CompletedPrimary

Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™

NCT04572854Phase 2Completed

Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN

NCT06288152Not ApplicableRecruitingPrimary

Evaluation of Thiosulfate Enhanced Organ Preservation Solution in Kidney Transplantation

NCT07392996Active Not RecruitingPrimary

Does Early Postoperative Fluid Management Affect Functional Delayed Graft Function After Living Donor Kidney Transplantation?

NCT07348874Not Yet Recruiting

Predictive Accuracy of Machine Perfusion for Kidney Transplant Outcomes in Germany

NCT07197164Phase 2Recruiting

Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients

NCT07181096Not ApplicableRecruiting

Frailty Among Renal Transplant Recipients and Relation to Chronic Allograft Dysfunction

NCT05632523CompletedPrimary

Early Pharmacological and Immune Monitoring After Conversion to Belatacept in Renal Transplant Patients

NCT07065734Phase 4Recruiting

NEgative prEssure Wound Therapy in Renal Transplant

NCT02711826Phase 1Completed

Treg Therapy in Subclinical Inflammation in Kidney Transplantation

NCT06836544Not ApplicableCompletedPrimary

Efficacy of the ALL YOU NEED is LOVE Healthcare Transition Syllabus Among Pre- and Posttransplant Adolescents in Cali, Colombia

NCT05104242Not ApplicableCompletedPrimary

Kidney Transplant Low-AGE Diet Study

NCT06707272CompletedPrimary

A Study of the Correlation Between Donor UDP-Glc and Transplanted Kidney Function

NCT06025240Recruiting

Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients

NCT04711291Not ApplicableWithdrawn

Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose Changes

Scroll to load more

Research Network

Activity Timeline